| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.03 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |